My cravings are way more manageable, and my energy levels feel steadier throughout the day
On the heels of basic research on the venom of Gila monsters in the preceding decades,1 exenatide secured the first US FDA approval in the class on April 28, 2005.2 While the prominent GLP-1 brand names are household names today, the class was off to a relatively slow start at first five years passed before it reached blockbuster status (US$1 billion (770 million) in sales), and another five went by before the first formal approval of a GLP-1 drug indicated for obesity became a reality.3 Last year saw sales for the class cross $50 billion and, with another 40% in revenue growth in store for 2025, the GLP-1 segment of the pharmaceutical industry is firmly in the rapid growth phase of the market, per Investment Bank Consensus
Eli Lilly, which sells Zepbound and Mounjaro, just released a blockbuster Q2 this morning, beating Wall Street projections and raising its 2025 sales guidance
Explore More at Pharmeasy Manufacturer Details Brand:DEPIGLOW Manufacturer Name:GRACE DERMA HEALTHCARE PVT LTD Address:AETHERIX LIFESCIENCE PVT
Additionally, the stable form of Retinol used in the Serum improves its anti-aging activity
You may qualify if you: Struggle with persistent hunger or cravings Have difficulty losing weight despite effort Experience metabolic resistance Want physician-guided medical care Are ready for a structured approach Eligibility is determined after consultation and laboratory review